REPORTS

Let’s Pullulate and Expand Your Business

Global Dengue Vaccine Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

Jul 15, 2020  |  154 PAGES  |  REPORT CODE: CMM373128
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The Aedes aegypti mosquito is responsible for transmitting the dengue virus (DENV). The virus that causes dengue belongs to the Flavivirus genus of the Flaviviridae family. Dengue fever resembles influenza and affects adults, children, as well as infants, but it is rarely fatal. However, dengue hemorrhagic fever is a potentially fatal complication because of multiple factors such as fluid accumulation, severe bleeding, organ impairment, or plasma leaking.

The Dengue Vaccine is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 3.6% during the forecast period. The research provides insights for the global Dengue Vaccine market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Dengue Vaccine industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

The Snapshot of Global Dengue Vaccine Market Segmentations:

By Players:

  • GlaxoSmithKline

  • Merck Sharp & Dohme

  • Sanofi

  • Takeda Pharmaceuticals

  • GeneOne Life Sciences

  • Medigen Biologics

  • Panacea Biotec

  • Sun Pharmaceutical

  • Vabiotec

By Types:

  • CYD-TDV

  • DENVax or TAK-003

  • TetraVax-DV

  • TDENV PIV

  • V180

  • DNA vaccines

By End-User:

  • Government institutions

  • Hospitals

  • NGOs

By Regions:

North America

  • United States

  • Canada

  • Mexico

Europe

  • Germany

  • UK

  • France

  • Italy

  • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

  • Spain

  • Belgium

  • Poland

  • Russia

  • Turkey

  • Others

Asia-Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia and New Zealand

  • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

Latin America, Middle East & Africa

  • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

  • Brazil

  • Nigeria

  • South Africa

  • Argentina

  • Others

Table of Contents

1 Report Overview

  • 1.1 Product Definition and Scope

  • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Dengue Vaccine Market

  • 1.3 Market Segmentation by Type

    • 1.3.1 Global Dengue Vaccine Market Size and Growth Rate of CYD-TDV from 2014 to 2026

    • 1.3.2 Global Dengue Vaccine Market Size and Growth Rate of DENVax or TAK-003 from 2014 to 2026

    • 1.3.3 Global Dengue Vaccine Market Size and Growth Rate of TetraVax-DV from 2014 to 2026

    • 1.3.4 Global Dengue Vaccine Market Size and Growth Rate of TDENV PIV from 2014 to 2026

    • 1.3.5 Global Dengue Vaccine Market Size and Growth Rate of V180 from 2014 to 2026

    • 1.3.6 Global Dengue Vaccine Market Size and Growth Rate of DNA vaccines from 2014 to 2026

  • 1.4 Market Segmentation by End-Users

    • 1.4.1 Global Dengue Vaccine Market Size and Growth Rate of Government institutions from 2014 to 2026

    • 1.4.2 Global Dengue Vaccine Market Size and Growth Rate of Hospitals from 2014 to 2026

    • 1.4.3 Global Dengue Vaccine Market Size and Growth Rate of NGOs from 2014 to 2026

  • 1.5 Market Segmentation by Regions

    • 1.5.1 North America Dengue Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.1 United States Dengue Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.2 Canada Dengue Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.3 Mexico Dengue Vaccine Market Size and Growth Rate from 2014 to 2026

    • 1.5.2 Europe Dengue Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.1 Germany Dengue Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.2 UK Dengue Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.3 France Dengue Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.4 Italy Dengue Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.5 Nordic Countries Dengue Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.6 Spain Dengue Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.7 Belgium Dengue Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.8 Poland Dengue Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.9 Russia Dengue Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.10 Turkey Dengue Vaccine Market Size and Growth Rate from 2014 to 2026

    • 1.5.3 Asia-Pacific Dengue Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.1 China Dengue Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.2 Japan Dengue Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.3 Australia and New Zealand Dengue Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.4 India Dengue Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.5 ASEAN Countries Dengue Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.6 South Korea Dengue Vaccine Market Size and Growth Rate from 2014 to 2026

    • 1.5.4 Latin America, Middle East & Africa Dengue Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.1 GCC Countries Dengue Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.2 Brazil Dengue Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.3 Nigeria Dengue Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.4 South Africa Dengue Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.5 Argentina Dengue Vaccine Market Size and Growth Rate from 2014 to 2026

2 Market Trends and Competitive Landscape

  • 2.1 Market Trends and Dynamics

    • 2.1.1 Market Challenges and Restraints 

    • 2.1.2 Market Opportunities and Potentials

    • 2.1.3 Mergers and Acquisitions

  • 2.2 Competitive Landscape Analysis

    • 2.2.1 Industrial Concentration Analysis

    • 2.2.2 Porter's Five Forces Analysis of the Industry

    • 2.2.3 SWOT Analysis for New Entrants

3 Segmentation of Dengue Vaccine Market by Types

  • 3.1 Product Development Trends of Different Types

  • 3.2 Commercial Product Types of Major Vendors

  • 3.3 Competitive Landscape Analysis of Different Types

  • 3.4 Market Size of Dengue Vaccine by Major Types

    • 3.4.1 Dengue Vaccine Market Size and Growth Rate of CYD-TDV

    • 3.4.2 Dengue Vaccine Market Size and Growth Rate of DENVax or TAK-003

    • 3.4.3 Dengue Vaccine Market Size and Growth Rate of TetraVax-DV

    • 3.4.4 Dengue Vaccine Market Size and Growth Rate of TDENV PIV

    • 3.4.5 Dengue Vaccine Market Size and Growth Rate of V180

    • 3.4.6 Dengue Vaccine Market Size and Growth Rate of DNA vaccines

4 Segmentation of Dengue Vaccine Market by End-Users

  • 4.1 Downstream Client Analysis by End-Users

  • 4.2 Competitive Landscape Analysis of Different End-Users

  • 4.3 Market Potential Analysis of Different End-Users

  • 4.4 Market Size of Dengue Vaccine by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Dengue Vaccine in Government institutions

    • 4.4.2 Market Size and Growth Rate of Dengue Vaccine in Hospitals

    • 4.4.3 Market Size and Growth Rate of Dengue Vaccine in NGOs

5 Market Analysis by Major Regions

  • 5.1 Global Dengue Vaccine Production Analysis by Major Regions

  • 5.2 Global Dengue Vaccine Consumption Analysis by Major Regions

  • 5.3 Global Dengue Vaccine Production, Import, Consumption and Export Analysis by Regions

    • 5.3.1 North America Dengue Vaccine Production, Import, Consumption and Export Analysis 

    • 5.3.2 Europe Dengue Vaccine Production, Import, Consumption and Export Analysis

    • 5.3.3 Asia Pacific Dengue Vaccine Production, Import, Consumption and Export Analysis

    • 5.3.4 Latin America, Middle East & Africa Dengue Vaccine Production, Import, Consumption and Export Analysis

6 Product Commodity of Dengue Vaccine Market in Major Countries

  • 6.1 Top 5 Export Countries in Dengue Vaccine market from 2014 to 2019

    • 6.1.1 Top 5 Export Countries' Export Value Analysis in Dengue Vaccine market from 2014 to 2019

    • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Dengue Vaccine market from 2014 to 2019

  • 6.2 Top 5 Import Countries in Dengue Vaccine market from 2014 to 2019

    • 6.2.1 Top 5 Import Countries' Import Value Analysis in Dengue Vaccine market from 2014 to 2019

    • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Dengue Vaccine market from 2014 to 2019

  • 6.3 Emerging Top 3 Export Countries Analysis

  • 6.4 Emerging Top 3 Import Countries Analysis

7 North America Dengue Vaccine Landscape Analysis

  • 7.1 North America Dengue Vaccine Landscape Analysis by Major Types

  • 7.2 North America Dengue Vaccine Landscape Analysis by Major End-Users

  • 7.3 North America Dengue Vaccine Landscape Analysis by Major Countries

    • 7.3.1 United States Dengue Vaccine Market Volume and Growth Rate

    • 7.3.2 Canada Dengue Vaccine Market Volume and Growth Rate

    • 7.3.3 Mexico Dengue Vaccine Market Volume and Growth Rate

8 Europe Dengue Vaccine Landscape Analysis

  • 8.1 Europe Dengue Vaccine Landscape Analysis by Major Types

  • 8.2 Europe Dengue Vaccine Landscape Analysis by Major End-Users

  • 8.3 Europe Dengue Vaccine Landscape Analysis by Major Countries

    • 8.3.1 Germany Dengue Vaccine Market Volume and Growth Rate

    • 8.3.2 UK Dengue Vaccine Market Volume and Growth Rate

    • 8.3.3 France Dengue Vaccine Market Volume and Growth Rate

    • 8.3.4 Italy Dengue Vaccine Market Volume and Growth Rate

    • 8.3.5 Nordic Countries Dengue Vaccine Market Volume and Growth Rate

    • 8.3.6 Spain Dengue Vaccine Market Volume and Growth Rate

    • 8.3.7 Belgium Dengue Vaccine Market Volume and Growth Rate

    • 8.3.8 Poland Dengue Vaccine Market Volume and Growth Rate

    • 8.3.9 Russia Dengue Vaccine Market Volume and Growth Rate

    • 8.3.10 Turkey Dengue Vaccine Market Volume and Growth Rate

9 Asia Pacific Dengue Vaccine Landscape Analysis

  • 9.1 Asia Pacific Dengue Vaccine Landscape Analysis by Major Types

  • 9.2 Asia Pacific Dengue Vaccine Landscape Analysis by Major End-Users

  • 9.3 Asia Pacific Dengue Vaccine Landscape Analysis by Major Countries

    • 9.3.1 China Dengue Vaccine Market Volume and Growth Rate

    • 9.3.2 Japan Dengue Vaccine Market Volume and Growth Rate

    • 9.3.3 Australia and New Zealand Dengue Vaccine Market Volume and Growth Rate

    • 9.3.4 India Dengue Vaccine Market Volume and Growth Rate

    • 9.3.5 ASEAN Countries Dengue Vaccine Market Volume and Growth Rate

    • 9.3.6 South Korea Dengue Vaccine Market Volume and Growth Rate

10 Latin America, Middle East & Africa Dengue Vaccine Landscape Analysis

  • 10.1 Latin America, Middle East & Africa Dengue Vaccine Landscape Analysis by Major Types

  • 10.2 Latin America, Middle East & Africa Dengue Vaccine Landscape Analysis by Major End-Users

  • 10.3 Latin America, Middle East & Africa Dengue Vaccine Landscape Analysis by Major Countries

    • 10.3.1 GCC Countries Dengue Vaccine Market Volume and Growth Rate

    • 10.3.2 Brazil Dengue Vaccine Market Volume and Growth Rate

    • 10.3.3 Nigeria Dengue Vaccine Market Volume and Growth Rate

    • 10.3.4 South Africa Dengue Vaccine Market Volume and Growth Rate 

    • 10.3.5 Argentina Dengue Vaccine Market Volume and Growth Rate

11 Major Players Profile

  • 11.1 GlaxoSmithKline

    • 11.1.1 GlaxoSmithKline Company Profile and Recent Development

    • 11.1.2 Market Performance

    • 11.1.3 Product and Service Introduction

  • 11.2 Merck Sharp & Dohme

    • 11.2.1 Merck Sharp & Dohme Company Profile and Recent Development

    • 11.2.2 Market Performance

    • 11.2.3 Product and Service Introduction

  • 11.3 Sanofi

    • 11.3.1 Sanofi Company Profile and Recent Development

    • 11.3.2 Market Performance

    • 11.3.3 Product and Service Introduction

  • 11.4 Takeda Pharmaceuticals

    • 11.4.1 Takeda Pharmaceuticals Company Profile and Recent Development

    • 11.4.2 Market Performance

    • 11.4.3 Product and Service Introduction

  • 11.5 GeneOne Life Sciences

    • 11.5.1 GeneOne Life Sciences Company Profile and Recent Development

    • 11.5.2 Market Performance

    • 11.5.3 Product and Service Introduction

  • 11.6 Medigen Biologics

    • 11.6.1 Medigen Biologics Company Profile and Recent Development

    • 11.6.2 Market Performance

    • 11.6.3 Product and Service Introduction

  • 11.7 Panacea Biotec

    • 11.7.1 Panacea Biotec Company Profile and Recent Development

    • 11.7.2 Market Performance

    • 11.7.3 Product and Service Introduction

  • 11.8 Sun Pharmaceutical

    • 11.8.1 Sun Pharmaceutical Company Profile and Recent Development

    • 11.8.2 Market Performance

    • 11.8.3 Product and Service Introduction

  • 11.9 Vabiotec

    • 11.9.1 Vabiotec Company Profile and Recent Development

    • 11.9.2 Market Performance

    • 11.9.3 Product and Service Introduction

12 Data Source and Research Methodology

The List of Tables and Figures (Totals 119 Figures and 210 Tables)

  • Figure Product Picture

  • Figure Dengue Vaccine Market Size and Growth Rate of CYD-TDV from 2014 to 2026

  • Figure Dengue Vaccine Market Size and Growth Rate of DENVax or TAK-003 from 2014 to 2026

  • Figure Dengue Vaccine Market Size and Growth Rate of TetraVax-DV from 2014 to 2026

  • Figure Dengue Vaccine Market Size and Growth Rate of TDENV PIV from 2014 to 2026

  • Figure Dengue Vaccine Market Size and Growth Rate of V180 from 2014 to 2026

  • Figure Dengue Vaccine Market Size and Growth Rate of DNA vaccines from 2014 to 2026

  • Figure Market Share by Type in 2014

  • Figure Market Share by Type in 2018

  • Figure Market Share by Type in 2026

  • Figure Global Dengue Vaccine Market Size and Growth Rate of Government institutions from 2014 to 2026

  • Figure Global Dengue Vaccine Market Size and Growth Rate of Hospitals from 2014 to 2026

  • Figure Global Dengue Vaccine Market Size and Growth Rate of NGOs from 2014 to 2026

  • Figure Market Share by End-User in 2014

  • Figure Market Share by End-User in 2018

  • Figure Market Share by End-User in 2026

  • Figure North America Dengue Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure United States Dengue Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Canada Dengue Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Mexico Dengue Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Europe Dengue Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Germany Dengue Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure UK Dengue Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure France Dengue Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Italy Dengue Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Dengue Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Spain Dengue Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Belgium Dengue Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Poland Dengue Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Russia Dengue Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Turkey Dengue Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Asia-Pacific Dengue Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure China Dengue Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Japan Dengue Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Australia and New Zealand Dengue Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure India Dengue Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Dengue Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Korea Dengue Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Latin America, Middle East & Africa Dengue Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure GCC Countries Dengue Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Brazil Dengue Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nigeria Dengue Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Africa Dengue Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Argentina Dengue Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Development Trends and Industry Dynamics of Dengue Vaccine Industry

  • Figure Market Challenges and Restraints

  • Figure Market Opportunities and Potentials

  • Table Mergers and Acquisition

  • Figure Market Share of TOP 3 Players in 2018

  • Figure Market Share of TOP 5 Players in 2018

  • Figure Market Share of TOP 6 Players from 2014 to 2019

  • Figure Porter's Five Forces Analysis

  • Figure New Entrant SWOT Analysis

  • Table Specifications of Different Types of Dengue Vaccine

  • Figure Development Trends of Different Types

  • Table Commercial Products Types of Major Vendors

  • Figure Competitive Landscape Analysis of Different Types

  • Table Consumption of Dengue Vaccine by Different Types from 2014 to 2026

  • Table Consumption Share of Dengue Vaccine by Different Types from 2014 to 2026

  • Figure Market Size and Growth Rate of CYD-TDV

  • Figure Market Size and Growth Rate of DENVax or TAK-003

  • Figure Market Size and Growth Rate of TetraVax-DV

  • Figure Market Size and Growth Rate of TDENV PIV

  • Figure Market Size and Growth Rate of V180

  • Figure Market Size and Growth Rate of DNA vaccines

  • Table Downstream Client Analysis by End-Users

  • Figure Competitive Landscape Analysis of Different End-Users

  • Table Market Potential Analysis of Different End-Users

  • Table Consumption of Dengue Vaccine by Different End-Users from 2014 to 2026

  • Table Consumption Share of Dengue Vaccine by Different End-Users from 2014 to 2026

  • Figure Market Size and Growth Rate of Government institutions

  • Figure Market Size and Growth Rate of Hospitals

  • Figure Market Size and Growth Rate of NGOs

  • Table Global Dengue Vaccine Production by Major Regions

  • Table Global Dengue Vaccine Production Share by Major Regions

  • Figure Global Dengue Vaccine Production Share by Major Regions in 2014

  • Figure Global Dengue Vaccine Production Share by Major Regions in 2018

  • Figure Global Dengue Vaccine Production Share by Major Regions in 2026

  • Table Global Dengue Vaccine Consumption by Major Regions

  • Table Global Dengue Vaccine Consumption Share by Major Regions

  • Figure Global Dengue Vaccine Consumption Share by Major Regions in 2014

  • Figure Global Dengue Vaccine Consumption Share by Major Regions in 2018

  • Figure Global Dengue Vaccine Consumption Share by Major Regions in 2026

  • Table North America Dengue Vaccine Production, Import, Consumption and Export Analysis

  • Table Europe Dengue Vaccine Production, Import, Consumption and Export Analysis

  • Table Asia Pacific Dengue Vaccine Production, Import, Consumption and Export Analysis

  • Table Latin America, Middle East & Africa Dengue Vaccine Production, Import, Consumption and Export Analysis

  • Table Top 5 Export Countries' Export Value Analysis in Dengue Vaccine market from 2014 to 2019

  • Table Top 5 Export Countries' Export Volume Analysis in Dengue Vaccine market from 2014 to 2019

  • Table Top 5 Import Countries' Import Value Analysis in Dengue Vaccine market from 2014 to 2019

  • Table Top 5 Import Countries' Import Volume Analysis in Dengue Vaccine market from 2014 to 2019

  • Figure Emerging Top 3 Export Countries Analysis

  • Figure Emerging Top 3 Import Countries Analysis

  • Table North America Dengue Vaccine Consumption by Types from 2014 to 2026

  • Table North America Dengue Vaccine Consumption Share by Types from 2014 to 2026

  • Figure North America Dengue Vaccine Consumption Share by Types in 2014

  • Figure North America Dengue Vaccine Consumption Share by Types in 2018

  • Figure North America Dengue Vaccine Consumption Share by Types in 2026

  • Table North America Dengue Vaccine Consumption by End-Users from 2014 to 2026

  • Table North America Dengue Vaccine Consumption Share by End-Users from 2014 to 2026

  • Figure North America Dengue Vaccine Consumption Share by End-Users in 2014

  • Figure North America Dengue Vaccine Consumption Share by End-Users in 2018

  • Figure North America Dengue Vaccine Consumption Share by End-Users in 2026

  • Table North America Dengue Vaccine Consumption by Major Countries from 2014 to 2026

  • Table North America Dengue Vaccine Consumption Share by Major Countries from 2014 to 2026

  • Figure North America Dengue Vaccine Consumption Share by Major Countries in 2014

  • Figure North America Dengue Vaccine Consumption Share by Major Countries in 2018

  • Figure North America Dengue Vaccine Consumption Share by Major Countries in 2026

  • Figure United States Dengue Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure Canada Dengue Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure Mexico Dengue Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Table Europe Dengue Vaccine Consumption by Types from 2014 to 2026

  • Table Europe Dengue Vaccine Consumption Share by Types from 2014 to 2026

  • Figure Europe Dengue Vaccine Consumption Share by Types in 2014

  • Figure Europe Dengue Vaccine Consumption Share by Types in 2018

  • Figure Europe Dengue Vaccine Consumption Share by Types in 2026

  • Table Europe Dengue Vaccine Consumption by End-Users from 2014 to 2026

  • Table Europe Dengue Vaccine Consumption Share by End-Users from 2014 to 2026

  • Figure Europe Dengue Vaccine Consumption Share by End-Users in 2014

  • Figure Europe Dengue Vaccine Consumption Share by End-Users in 2018

  • Figure Europe Dengue Vaccine Consumption Share by End-Users in 2026

  • Table Europe Dengue Vaccine Consumption by Major Countries from 2014 to 2026

  • Table Europe Dengue Vaccine Consumption Share by Major Countries from 2014 to 2026

  • Figure Europe Dengue Vaccine Consumption Share by Major Countries in 2014

  • Figure Europe Dengue Vaccine Consumption Share by Major Countries in 2018

  • Figure Europe Dengue Vaccine Consumption Share by Major Countries in 2026

  • Figure Germany Dengue Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure UK Dengue Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure France Dengue Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure Italy Dengue Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Dengue Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure Belgium Dengue Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure Poland Dengue Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure Russia Dengue Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure Turkey Dengue Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Table Asia Pacific Dengue Vaccine Consumption by Types from 2014 to 2026

  • Table Asia Pacific Dengue Vaccine Consumption Share by Types from 2014 to 2026

  • Figure Asia Pacific Dengue Vaccine Consumption Share by Types in 2014

  • Figure Asia Pacific Dengue Vaccine Consumption Share by Types in 2018

  • Figure Asia Pacific Dengue Vaccine Consumption Share by Types in 2026

  • Table Asia Pacific Dengue Vaccine Consumption by End-Users from 2014 to 2026

  • Table Asia Pacific Dengue Vaccine Consumption Share by End-Users from 2014 to 2026

  • Figure Asia Pacific Dengue Vaccine Consumption Share by End-Users in 2014

  • Figure Asia Pacific Dengue Vaccine Consumption Share by End-Users in 2018

  • Figure Asia Pacific Dengue Vaccine Consumption Share by End-Users in 2026

  • Table Asia Pacific Dengue Vaccine Consumption by Major Countries from 2014 to 2026

  • Table Asia Pacific Dengue Vaccine Consumption Share by Major Countries from 2014 to 2026

  • Figure Asia Pacific Dengue Vaccine Consumption Share by Major Countries in 2014

  • Figure Asia Pacific Dengue Vaccine Consumption Share by Major Countries in 2018

  • Figure Asia Pacific Dengue Vaccine Consumption Share by Major Countries in 2026

  • Figure China Dengue Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure Japan Dengue Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure Australia and New ZealandDengue Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure India Dengue Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Dengue Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure South Korea Dengue Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Table Latin America, Middle East & Africa Dengue Vaccine Consumption by Types from 2014 to 2026

  • Table Latin America, Middle East & Africa Dengue Vaccine Consumption Share by Types from 2014 to 2026

  • Figure Latin America, Middle East & Africa Dengue Vaccine Consumption Share by Types in 2014

  • Figure Latin America, Middle East & Africa Dengue Vaccine Consumption Share by Types in 2018

  • Figure Latin America, Middle East & Africa Dengue Vaccine Consumption Share by Types in 2026

  • Table Latin America, Middle East & Africa Dengue Vaccine Consumption by End-Users from 2014 to 2026

  • Table Latin America, Middle East & Africa Dengue Vaccine Consumption Share by End-Users from 2014 to 2026

  • Figure Latin America, Middle East & Africa Dengue Vaccine Consumption Share by End-Users in 2014

  • Figure Latin America, Middle East & Africa Dengue Vaccine Consumption Share by End-Users in 2018

  • Figure Latin America, Middle East & Africa Dengue Vaccine Consumption Share by End-Users in 2026

  • Table Latin America, Middle East & Africa Dengue Vaccine Consumption by Major Countries from 2014 to 2026

  • Table Latin America, Middle East & Africa Dengue Vaccine Consumption Share by Major Countries from 2014 to 2026

  • Figure Latin America, Middle East & Africa Dengue Vaccine Consumption Share by Major Countries in 2014

  • Figure Latin America, Middle East & Africa Dengue Vaccine Consumption Share by Major Countries in 2018

  • Figure Latin America, Middle East & Africa Dengue Vaccine Consumption Share by Major Countries in 2026

  • Figure GCC Countries Dengue Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure Brazil Dengue Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure Nigeria Dengue Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure South Africa Dengue Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure Argentina Dengue Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Table Company Profile and Development Status of GlaxoSmithKline

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

  • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

  • Figure Revenue and Market Share Analysis of GlaxoSmithKline

  • Table Product and Service Introduction of GlaxoSmithKline

  • Table Company Profile and Development Status of Merck Sharp & Dohme

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck Sharp & Dohme

  • Figure Sales and Growth Rate Analysis of Merck Sharp & Dohme

  • Figure Revenue and Market Share Analysis of Merck Sharp & Dohme

  • Table Product and Service Introduction of Merck Sharp & Dohme

  • Table Company Profile and Development Status of Sanofi

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

  • Figure Sales and Growth Rate Analysis of Sanofi

  • Figure Revenue and Market Share Analysis of Sanofi

  • Table Product and Service Introduction of Sanofi

  • Table Company Profile and Development Status of Takeda Pharmaceuticals

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceuticals

  • Figure Sales and Growth Rate Analysis of Takeda Pharmaceuticals

  • Figure Revenue and Market Share Analysis of Takeda Pharmaceuticals

  • Table Product and Service Introduction of Takeda Pharmaceuticals

  • Table Company Profile and Development Status of GeneOne Life Sciences

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GeneOne Life Sciences

  • Figure Sales and Growth Rate Analysis of GeneOne Life Sciences

  • Figure Revenue and Market Share Analysis of GeneOne Life Sciences

  • Table Product and Service Introduction of GeneOne Life Sciences

  • Table Company Profile and Development Status of Medigen Biologics

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Medigen Biologics

  • Figure Sales and Growth Rate Analysis of Medigen Biologics

  • Figure Revenue and Market Share Analysis of Medigen Biologics

  • Table Product and Service Introduction of Medigen Biologics

  • Table Company Profile and Development Status of Panacea Biotec

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Panacea Biotec

  • Figure Sales and Growth Rate Analysis of Panacea Biotec

  • Figure Revenue and Market Share Analysis of Panacea Biotec

  • Table Product and Service Introduction of Panacea Biotec

  • Table Company Profile and Development Status of Sun Pharmaceutical

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sun Pharmaceutical

  • Figure Sales and Growth Rate Analysis of Sun Pharmaceutical

  • Figure Revenue and Market Share Analysis of Sun Pharmaceutical

  • Table Product and Service Introduction of Sun Pharmaceutical

  • Table Company Profile and Development Status of Vabiotec

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vabiotec

  • Figure Sales and Growth Rate Analysis of Vabiotec

  • Figure Revenue and Market Share Analysis of Vabiotec

  • Table Product and Service Introduction of Vabiotec


Report Purchase

reports
$4480
$8960
BUY NOWClick MeBUY NOW
top